The article by Lauder et al. [1] , just published in TheScientificWorldJOURNAL, provides an analysis of the results of treatment for end-stage kidney disease in Italy and explores the possible reasons for the excellent outcomes. It is based on data collected in a survey of about 25% of the Italian dialysis centers with an annual mortality of 12%, which is far below the European mortality rate and strikingly lower than the mortality rate in the U.S.
system and the focus of medical care played a role beyond other metrics of quality, such as the achievement of the goal hemoglobin level or the kT/V. In fact, as noted in the paper by Lauder et al., patients from the U.S. have better indicators of provision of effective dialysis and anemia management, but yet the mortality rate is higher than in Italy. The authors of this landmark survey center their analysis in aspects related to the delivery system of nephrological care in Italy, which is largely a public one. In this model, it is noteworthy that there is an integral approach to care, starting at the early phases of kidney disease. Seventy-five percent of patients are followed from phases CKD 3 and 4, and the models of provision of vascular access are integrated as well (about 25% involve an integrated approach between nephrologists and surgeons).
The follow-up of CKD from its earliest stages allows for adequate preparation of the patient prior to renal replacement therapies and is an element that has already shown to lead to good results [6] . The survey of the Italian system provides results that are above any other reference of which we are aware. In 1999, it was estimated that about half of patients in dialysis in Spain had been previously evaluated in consultation prior to dialysis [4] . In fact, it is noteworthy that the glomerular filtration rate at the initiation of dialysis was at about 10 ml/min. Although we do not have this information available at the majority of registries, one could think that initiation of dialysis early on contributes to low mortality rate. In CKD stages 3 and 4, one can also identify differences among countries [7] . In a Spanish study based on 1,100 patients followed for 5 years by nephrologists, the percentage of patients entering replacement therapy was 19.2% at 3 years and the mortality rate was 10.4%. It seems that the differences are already present at the predialysis phase regarding both population differences and during an integrated follow-up [8] .
In the article by Lauder et al. [1] , there was very little attention paid to home dialysis, fundamentally peritoneal dialysis, such that mortality and other details are not mentioned. In general, those patients are about 10 years younger and have less comorbidities than those on hemodialysis [9, 10] . In a collaborative Spanish study that involved over 450 patients on peritoneal dialysis, mortality was 5.4%, a figure below the Spanish registry [8, 9] , reflecting a selected sample from centers committed to this type of dialysis (an example of positive selection). The number one cause of termination of this mode of dialectic therapy is kidney transplantation, which occurs in 24% of patients that have been on peritoneal dialysis for a year.
The public health systems in the Mediterranean countries have a relatively high number of nephrologists per hundred thousand people. The task of the nephrologists in this environment revolves around teamwork and the frequent presence in dialysis treatment rooms. This accessibility may provide results that go beyond the careful clinical follow-up and the accomplishment of the "cold" goals and objectives that are part of the dialysis quality of care plans. Some authors have noted the importance of the amount of time spent in the dialysis center and with the patient; the infrequent number of visits by the dialysis physician was associated with a significant increase in mortality [11] . This conviction takes us back to the basics in the practice of Medicine: that the close relationship between the physician and the patient, at a time of technological dominance, continues to be fundamental to achieve good therapeutic results.
